Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$634,024,342
+$111,071,161 QoQ
Shares Held
2,519,569
+4.8% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#70
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 3%
None 55%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. ABBV ranks #1 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,024,342 | 2,519,569 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $522,953,181 | 2,404,493 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $548,894,670 | 2,402,270 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $533,935,638 | 2,306,019 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $404,886,036 | 2,181,263 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $427,598,681 | 2,040,849 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $367,368,804 | 2,067,354 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $431,976,835 | 2,187,446 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $493,370,417 | 2,876,460 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $525,782,609 | 2,887,329 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $457,706,218 | 2,953,515 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $478,623,012 | 3,210,942 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $424,144,319 | 3,148,106 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $507,622,772 | 3,185,184 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $522,809,318 | 3,235,006 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $436,960,245 | 3,255,795 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $500,255,171 | 3,266,226 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $553,311,418 | 3,413,185 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $477,545,102 | 3,526,921 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $384,443,824 | 3,563,955 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $396,343,100 | 3,518,671 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $382,376,213 | 3,533,323 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $375,870,090 | 3,507,887 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $304,593,083 | 3,477,487 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $372,972,563 | 3,798,865 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $288,736,859 | 3,789,695 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||